ÐÓ°ÉÔ­´´

TCR2 Therapeutics logo

TCR2 Therapeutics

TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.

1

Funding Rounds

$125.0m

Money raised

Overview

TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.
  • Website:
  • Headquarters: Cambridge, Massachusetts
  • Social accounts: